Paul Lin

Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial

David Marín, Ye Li, Rafet Başar et al. · Nature Medicine · 2024 · 457 citations · Full text

Life Sciences, Immunology, Oncology +17

MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation

Thomas J. Kean, Paul Lin, Arnold I. Caplan et al. · Stem Cells International · 2013 · 449 citations · Full text

Pharmacy, Bioengineering, Cell Biology +17

Assessing Porcine Liver-Derived Biomatrix for Hepatic Tissue Engineering

Paul Lin, Warren C. W. Chan, Stephen F. Badylak et al. · Tissue Engineering · 2004 · 239 citations

Engineering, Bioengineering, Biomedical Engineering +17

Endoscopic submucosal dissection for the treatment of intraluminal gastric subepithelial tumors originating from the muscularis propria layer

I.-L. Lee, Paul Lin, Shui‐Yi Tung et al. · Endoscopy · 2006 · 185 citations

Medicine, Oncology, Surgery +17

Targeting Improves MSC Treatment of Inflammatory Bowel Disease

In Kap Ko, Byung‐Gyu Kim, Amad Awadallah et al. · Molecular Therapy · 2010 · 177 citations · Full text

Medicine, Biomedical Sciences, Immunology +17